【摘要】：目的：槲皮素甲基化改造得到的五甲基槲皮素（PMQ），對(duì)心肌缺血再灌注損傷具有保護(hù)作用。本實(shí)驗(yàn)采用原代SD大鼠乳鼠心肌細(xì)胞，建立心肌缺氧/復(fù)氧（anoxia/re-oxygenation, A/R）損傷模型，探討五甲基槲皮素預(yù)處理對(duì)大鼠心肌細(xì)胞缺氧/復(fù)氧損傷的保護(hù)作用及其對(duì)線粒體功能的影響。 方法：培養(yǎng)原代SD大鼠乳鼠心肌細(xì)胞，隨機(jī)分為8組，每組實(shí)驗(yàn)重復(fù)3次：（1）正常對(duì)照組（Cont）；（2）Cont+DMSO組；（3）缺氧/復(fù)氧組（A/R）；（4）A/R+DMSO組；（5）缺氧預(yù)適應(yīng)的延遲相組（DPC）；（6）10μmol/L PMQ+A/R組；（7）30μmol/L PMQ+A/R組；（8）100μmol/L PMQ+A/R組。用MTT比色法檢測細(xì)胞存活率,Beckman生化自動(dòng)分析儀檢測培養(yǎng)液中乳酸脫氫酶(LDH)活性，，酶聯(lián)免疫檢測儀測定各組脂質(zhì)過氧化物丙二醛（MDA）含量、抗氧化物酶（SOD）活性、谷胱甘肽過氧化物酶（GSH-Px）的活性；流式細(xì)胞法檢測線粒體膜電位（Δψm）以及細(xì)胞凋亡情況、線粒體腫脹法檢測各組心肌細(xì)胞線粒體通透性轉(zhuǎn)換孔(mPTP)開放情況。 結(jié)果：與Cont組相比，A/R組的各項(xiàng)指標(biāo)均顯示細(xì)胞凋亡增加（P0.01）,說明A/R模型構(gòu)建成功；與A/R組相比，DPC組的各項(xiàng)指標(biāo)均顯示細(xì)胞凋亡減少，說明DPC模型構(gòu)建成功（P0.01）；與A/R組相比，不同劑量PMQ (10,30,100μmol/L)預(yù)處理24h組，其呈現(xiàn)劑量依賴性的使LDH活性降低、細(xì)胞存活率增加、MDA含量顯著減少、SOD酶活性顯著上升、GSH-Px酶活性顯著上升、細(xì)胞凋亡減少（P0.05或P0.01）；與A/R組相比，30,100μmol/L PMQ預(yù)處理24h組，其線粒體膜電位更為穩(wěn)定、mPTP開放減少（P0.05或P0.01）。 結(jié)論：PMQ預(yù)處理24h后，可產(chǎn)生藥理性延遲保護(hù)作用，其作用機(jī)制與抑制氧化應(yīng)激、穩(wěn)定線粒體膜電位、抑制mPTP開放，進(jìn)而減少細(xì)胞凋亡有關(guān)。
[Abstract]:Aim: to study the protective effect of pentamethylquercetin (PMQ), on myocardial ischemia reperfusion injury. In this study, we established myocardial hypoxia / reoxygenation (anoxia/re-oxygenation, A / R) injury model by primary SD rat neonatal cardiomyocytes, and investigated the protective effect of pentamethylquercetin preconditioning on hypoxia / reoxygenation injury of rat cardiomyocytes and its effect on mitochondrial function. Methods: primary SD rat cardiomyocytes were cultured and randomly divided into 8 groups: (1) normal control group (Cont); (2) Cont DMSO group, (3) anoxic / reoxygenated group (A / R); (4) A / R DMSO group, (5) anoxic preconditioning delayed phase group (DPC); (6) 10 渭 mol/L PMQ A / R group, and (3) anoxia / reoxygenation group (A / R); (4) A / R DMSO group. (7) 30 渭 mol/L PMQ A / R group and (8) 100 渭 mol/L PMQ A / R group. The cell survival rate was detected by MTT colorimetry, the activity of lactate dehydrogenase (LDH) was detected by Beckman biochemical automatic analyzer, the content of lipid peroxide malondialdehyde (MDA) and the activity of antioxidant enzyme (SOD) (SOD) were measured by enzyme-linked immunosorbent assay (Elisa). The activity of glutathione peroxidase (GSH-Px), mitochondrial membrane potential (螖 蠄 m) and apoptosis were detected by flow cytometry, and the opening of mitochondrial permeability transition pore (mPTP) was detected by mitochondrial swelling method. Results: compared with the Cont group, all the indexes in the A / R group showed an increase in apoptosis (P0.01), which indicated that the A / R model was successfully constructed, the DPC group showed a decrease in apoptosis, which indicated that the DPC model was successfully constructed (P0.01), and compared with the A / R group, all the indexes in the DPC group showed that the model was successfully constructed (P0.01). After pretreatment with different doses of PMQ (10 ~ 30100 渭 mol/L) for 24 h, the LDH activity decreased in a dose-dependent manner, the cell survival rate increased, the MDA content decreased, the activity of SOD increased significantly, the activity of GSH-Px increased significantly and the apoptosis of cells decreased in a dose-dependent manner (P0.05 or P0.01). Compared with the A / R group, the mitochondrial membrane potential of 30100 渭 mol/L PMQ pretreated for 24 hours was more stable and the opening of mPTP was decreased (P0.05 or P0.01). Conclusion: after pretreatment with PMQ for 24 h, the pharmacological delayed protective effect can be produced. The mechanism is related to the inhibition of oxidative stress, the stabilization of mitochondrial membrane potential, the inhibition of opening of mPTP, and the reduction of apoptosis.
【學(xué)位授予單位】：南昌大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2014
【分類號(hào)】：R96

【參考文獻(xiàn)】

相關(guān)期刊論文 前8條

1 何歡;侯莉;黃璜;王金錢;范玫玫;何明;;冠欣舒膠囊對(duì)大鼠心肌細(xì)胞缺氧/復(fù)氧損傷保護(hù)作用的拆方實(shí)驗(yàn)研究[J];中國臨床藥理學(xué)與治療學(xué);2011年12期

2 李偉;沈明勤;陸曉暉;;中藥防治心肌缺血再灌注損傷作用機(jī)制的研究進(jìn)展[J];中華中醫(yī)藥雜志;2011年03期

3 張琳;鄧樹勛;郝選明;;運(yùn)動(dòng)與心肌細(xì)胞凋亡的線粒體機(jī)制[J];體育學(xué)刊;2010年03期

4 管煒云;何明;;線粒體通透性轉(zhuǎn)換孔與心肌細(xì)胞凋亡[J];實(shí)用臨床醫(yī)學(xué);2009年12期

5 舒毅;譚陶;張思宇;吳紅];;槲皮素的藥理學(xué)研究進(jìn)展[J];華西藥學(xué)雜志;2008年06期

6 張曉華;劉祖梅;何婷;楊斐;金滿文;;五甲基槲皮素對(duì)豚鼠心肌收縮力和電生理特性的影響[J];華中科技大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2008年06期

7 賴仲方;心肌細(xì)胞內(nèi)氯離子濃度與缺血再灌注期間心律失常的關(guān)聯(lián)[J];中國醫(yī)學(xué)科學(xué)院學(xué)報(bào);2002年02期

8 商雄躍;李敬遠(yuǎn);曾因明;;線粒體通透性轉(zhuǎn)運(yùn)孔道模型的研究進(jìn)展[J];國際麻醉學(xué)與復(fù)蘇雜志;2007年02期

本文編號(hào)：2267232